ABSTRACT Increasing antibiotic resistance is a major public health concern. Fluoroquinolones are used to treat and prevent poultry diseases worldwide. Fluoroquinolone resistance rates are high in their countries of use. The aim of this study was to evaluate the effect of an acids-based feed additive, as well as fluoroquinolone antibiotics, on the prevalence of antibioticresistant E. coli. A total of 480 broiler chickens (Ross 308) were randomly assigned to 3 treatments: a control group receiving a basal diet; a group receiving a feed additive (FA) based on formic acid, acetic acid and propionic acid; and an antibiotic enrofloxacin (AB) group given the same diet, but supplemented with enrofloxacin in water. A pooled fecal sample of one-dayold chicks was collected upon arrival at the experimental farm. On d 17 and d 38 of the trial, cecal samples from each of the 8 pens were taken, and the count of E. coli and antibiotic-resistant E. coli was determined.
INTRODUCTION
The efficacy of antibiotics has decreased due to the rapid emergence and dissemination of resistant bacteria (Sengupta et al., 2013) . The application of antibiotics for the treatment of disease, disease prevention, and growth promotion in food-producing animals provides favorable conditions for the selection, persistence and spread of antibiotic-resistant bacteria and their resistance determinants at the farm level Diarrassouba et al., 2007; Miranda et al., 2008; Furtula et al., 2010; da Costa et al., 2011; Burow et al., 2014) . Thus, resistance to antibiotics has become a global concern not only in human but also in animal health. Furthermore, antibiotic-resistant (AR) bacteria and determinants generated at the farm may spread to humans through direct contact, contamination of meat, or environmental pathways (Aarestrup et al., 2008; Dolejska et al., 2013) .
To study the emergence of antibiotic resistance (AR) in gram-negative bacteria, E. coli are widely accepted as indicator bacteria (Kaesbohrer et al., 2012) . They are commensal members of the normal gastrointestinal microbiota in humans and animals, can be rapidly altered by exposure to antibiotics, according to Francino (2016) , and act as an important pool of resistance determinants (Schjorring and Krogfelt, 2011) . Possible contamination of poultry meat with AR E. coli may also occur during slaughtering. Moreover, E. coli is also of widespread importance, as it is a major pathogen in commercially produced poultry that contributes to significant economic losses (Hammerum and Heuer, 2009 ).
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Antibiotic growth promoters were banned in the European Union in 2006 (European Commission, 2005) . Accordingly, poultry producers are searching for alternatives that claim to enhance the performance of broiler chickens. One alternative to antibiotics is the use of organic acids as feed additives (Adil et al., 2010) , as well as cinnamaldehyde-containing feed additives (Demir et al., 2005) . Organic acids and cinnamaldehyde can improve chicken performance through their antimicrobial activity (Helander et al., 1998; Raftari et al., 2009; Wang et al., 2009; Adil et al., 2010) , which improves protein and energy digestibility by reducing microbial competition with the host for nutrients. Additionally, organic acids lower the incidence of subclinical infections (Dibner and Buttin, 2002) , and both compounds are recognized as safe. Their antimicrobial activities against various types of bacteria were found to be similar to those of antibiotics (Helander et al., 1998; Raftari et al., 2009; Wang et al., 2009; Adil et al., 2010) . Thus, the supplementation of diets with acids results in lower numbers of pathogenic bacteria (Khan and Iqbal, 2015) , such as Salmonella, Campylobacter, and E. coli (Van Immerseel et al., 2006; da Costa et al., 2008; Gharib Naseri et al., 2012; Khan and Iqbal, 2015; Upadhyaya et al., 2015) .
The application of antibiotic classes in foodproducing animals with therapeutically useful analogs in human medicine is a public concern (Turnidge, 2004; Collignon, 2009; da Costa et al., 2011) . Fluoroquinolones are used to treat diseases in poultry in many countries worldwide (Randall et al., 2006) . Enrofloxacin is a representative fluoroquinolone prescribed for the prevention of early chick mortality and the reduction of the spread of pathogens (da Costa et al., 2011) . This antibiotic is licensed for use in poultry in many countries, including Brazil, China, and the European Union (German Federal Ministry of Health, 2016; Ministry of Agriculture of People's Republic of China, 2001; MAPA et al., 2008 ; Ministry of Agriculture of People's Republic of China, 2013; The office for registration of medicinal products, medical devices and biocidal products in Poland, 2016). Via de-ethylation of the ethyl group on the piperazine ring, enrofloxacin is metabolized to ciprofloxacin (Riviere and Papich (2009) , which is a very potent antibiotic in human medicine (Ovando et al., 2004) . Bacterial resistance to fluoroquinolone antibiotics has increased significantly since their introduction into medicine and agriculture in the late 1980s (Everett et al., 1996) . The percentage of resistance to ciprofloxacin in E. coli isolates from broilers in the European Union is approximately 66% (EFSA/ECDC et al., 2016) . Concerns about the development of fluoroquinolone-resistant Campylobacter species in poultry led to a withdrawal of enrofloxacin in poultry in the United States in 2005 (US Food and Drug Administration, 2005) . Furthermore, use of enrofloxacin may increase the level of resistance to nonfluoroquinolones (da Costa et al., 2011). Due to the antimicrobial activity of organic acids, the level of AR bacteria in the gastrointestinal tract of broilers may decrease. The present study therefore evaluates the effect of enrofloxacin and feed additives based on organic acids on the prevalence of AR E. coli in the gastrointestinal tract of broilers.
MATERIALS AND METHODS

Animals, Housing and Treatments
The animal experiment was conducted at the Center of Applied Animal Nutrition in Mank, Austria. All procedures involving animal handling and treatment were approved by the local state office "Amt der Niederösterreichischen Landesregierung Abteilung Agrarrecht," which is the authority for animal care in Lower Austria. The official number of the trial approval is LF1-TVG-39/030-2016. A total of 480 mixed-sex, one-day-old broiler chickens (Ross 308) were randomly assigned to 3 treatments, with 8 pens per treatment and 20 birds per pen. All groups received a common basal diet without coccidiostats from hatch until 38 d of age. The composition of the starter and grower diets mets or exceeded the requirements of the National Research Council (1994) and is presented in Table 1 . Chicks had free access to feed and water supplied through nipple drinkers.
The first group of chickens was a negative control group fed a basal diet. The feed additive (FA) group also received the control group diet supplemented "on top" with a feed additive based on 20% formic, 10% acetic, and 5% propionic acids, as well as 2.5% cinnamaldehyde (Biotronic R Top3; BIOMIN Holding GmbH, Getzersdorf, Austria) at a dosage of 2 kg/t of feed. The antibiotic (AB) treatment group received the same diet as the control group, but 10 mg enrofloxacin per kg body weight (Baytril, 10% oral solution, Bayer, Leverkusen, Germany) was provided via drinking water from d 14 to d 16 of the trial, before the change to the grower diet.
All groups were subjected to the same rearing, environmental and sanitary conditions. Ventilation and temperature control, light intensity and day-length were applied according to the management handbook's guidelines (Aviagen, 2014) . Wood shavings were used for bedding. Clinical observations were done twice a day, and all incidents were recorded. The study was supervised by an independent, licensed local veterinarian.
Sampling
A pooled fecal sample of all 480 chicks was collected at arrival before the chicks were divided and placed into the pens. On d 17 of the trial, 3 chicks per pen were randomly selected and humanely euthanized by CO 2 . The intestinal tract of each chick was dissected after slaughter, and cecal samples were collected. Cecal samples from 3 chicks per pen were pooled to one sample. Therefore, 8 samples per group were collected, resulting in a total of 24 cecal samples. The same sampling procedure was used on d 38 of the trial.
Performance Data
Body weight (BW) by pen was calculated as an average of the sum of the weight of 20 birds on d 1 and 17, and as the average of individual animal weight on d 38 of the trial. Average daily weight gain (ADG) was calculated for the periods d 1 to 17, d 18 to 38, and d 1 to 38 of the trial. Penwise feed intake was recorded at d 17 and at the end of the trial (d 38). Average daily feed intake (ADFI) was calculated accordingly. The feed conversion rate (FCR) was calculated penwise. The European Production Efficiency Factor (EPEF) was calculated using the following formula EPEF = (Livability (Smyth et al., 2010) .
Microbiological Analysis
Intestinal samples were kept on ice during transport to the laboratory. All 49 samples were analyzed for E. coli, E. coli resistant to ampicillin, cefotaxime, ciprofloxacin, streptomycin, sulfamethoxazole, and tetracycline, and ESBL-producing E. coli within 24 h of arrival to the laboratory. A sample of approximately 3 g was filled to its 10-fold balance weight with buffered peptone water (Oxoid, Hampshire, United Kingdom) and homogenized (Stomacher R 400 Circulator, Seward Limited, UK). Using the first dilution, dilution series up to 10 -6 were prepared. For each dilution, 0.1 mL was spread in duplicate onto plates containing MacConkey agar (Merck, Darmstadt, Germany) and ChromlD ESBL medium (BioMérieux, Marcy-I'Étoile, France). Additionally, MacConkey agar respectively supplemented with one of the following antimicrobial agents at the corresponding breakpoint concentration (Clinical and Laboratory Standards Institute, 2012) was applied to obtain a maximum diversity of antibiotic-resistant E. coli: ampicillin (32 μg/mL), cefotaxim (4 μg/mL), ciprofloxacin (4 μg/mL), streptomycin (64 μg/mL), sulfamethoxazol (512 μg/mL) and tetracycline (16 μg/mL). All antibiotics originated from Sigma-Aldrich (St. Louis, USA). After incubating plates at 37
• C for 24 h, colonies typical for E. coli were enumerated on countable plates: red colonies surrounded by a turbid zone on MacConkey agar and pink to burgundy colonies or translucent colonies with a pink to burgundy center on ChromlD ESBL medium. The averages of duplicate plates were taken to calculate the number of CFU per gram sample.
Statistical Analysis
All normally distributed generated growth performance data (initial weight, BW d 17, ADG, d 1-17, ADFI, FCR, EPEF) were subjected to statistical analysis using analysis of variance (ANOVA) (IBM R SPSS R statistics 19.0). The non-normally distributed performance parameters (FI and BW d 38, ADG d 18-38, ADG d 1-38) were analyzed using a non-parametric Kruskal-Wallis test. The microbiological analyses were transformed into LOG prior to statistical evaluation. All normally distributed generated microbiological data were analyzed by means of ANOVA (IBM R SPSS R statistics 19.0). The non-normally distributed data were for E. coli resistant to cefotaxime and ESBLproducing E. coli, which were analyzed using a nonparametric Kruskal-Wallis test. The level of statistical significance for all measured parameters was expressed at P ≤ 0.05, and means were separated using the LSD test.
RESULTS AND DISCUSSION
Performance Data
The influence of FA and AB on poultry performance is shown in Table 2 . The results of the present study showed that dietary supplementation with FA enhanced (P ≤ 0.05) broiler growth performance (BW and EPEF) compared to the control group. There was no significant influence of AB (P ≤ 0.05) on the BW of birds compared to other feeding groups on d 17 and 38 of the trial. However, ADG was higher (P ≤ 0.05) in the FA and AB group compared to the control group. Animals from the group fed with FA were heavier (P ≤ 0.05) than the control group at the end of the trial. Nevertheless, feed intake was not affected by diet, but the FCR was lower (P ≤ 0.05) in the FA group compared to the control group. Compared to birds fed with basal diet, the EPEF was improved (P ≤ 0.05) by feeding FA.
A review of the role of organic acids in poultry nutrition confirms these results through comparison to other studies where organic acids were as efficient as, or even more efficient than, some antibiotics (Khan and Iqbal, 2015) . ADG and FCR of broiler chicks was significantly increased by supplementation with a formic and propionic acid mixture (Senkoylu et al., 2007) . The results of the study by Olarve et al. (2007) using 0.3 and 0.4% acidifier as a blend of formic, fumaric, lactic, propionic, and phosphoric acids in basal diets showed significant effects on the ADG and feed efficiency of broilers from d 28 to 42. Additionally, the use of fumaric, butyric, and lactic acids significantly improved BWG and FCR (Adil et al., 2010) . The improvement in ADG and FCR was possibly achieved due to better nutrient digestibility; Ghazalah et al. (2011) reported that feed supplementation with formic or fumaric acid and acetic or citric acid improved nutrient digestibility. Dietary supplementation of formic acid in the broiler finisher diet improved the apparent ileal digestibility of dry matter and crude protein (Hernandez et al., 2006; Garcia et al., 2007) . The positive effect of organic acids and cinnamaldehyde on performance may be due to a decrease in bacterial count, which will be discussed when considering the microbiological analysis. In the present study, continuous fed FA more efficiently improved growth performance than AB. Enrofloxacin is not used for growth promotion but is used for the treatment of disease, prevention of chick mortality, and reduction of the spread of pathogens (da Costa et al., 2011) . AB was provided to animals for 3 d according to the recommended use, which differs from the continuous application of in-feed antibiotics. A positive effect of enrofloxacin on growth performance was observed in ADG, but not BW, compared to the control group. There was no significant effect of enrofloxacin on growth performance in studies by da Costa et al. (2011) and Dibner and Richards (2005) .
Microbiological Analysis
Analysis of fecal samples on d 1 showed a total E. coli count of 8.18 log 10 CFU/g of fecal content. The number log 10 CFU/g of E. coli resistant to ampicillin was 7.83; cefotaxime, 2.40; ciprofloxacin, 8.00; streptomycin, 7.63; sulfamethoxazole, 7.56; tetracycline, 7.81; and ESBL-producing E. coli was at 2.82 log 10 CFU/g of fecal content. These results indicate that AR E. coli were already present in newborn chicks after transport without any access to water or feed. This finding corresponds to other published studies. Rashid et al. (2013) reported that E. coli from the gut, liver, and lungs of one-day-old chicks was multiresistant to amoxicillin, enrofloxacin, erythromycin, kanamycin, nalidixic acid, and cloxacillin. E. coli resistant to ampicillin, cefotaxime, tetracycline, streptomycin, gentamicin, and enrofloxacin from one-dayold chick's meconium was reported by da Costa et al. (2011) . Baron et al. (2014) also observed E. coli resistant to third-generation cephalosporins in one-dayold chicks. These authors suggest that the source of resistant E. coli may be eggshells or the immediate environment. Third-generation cephalosporins and fluoroquinolones are classified by the WHO as highestpriority critically important antibiotics, which means that this antibiotic is the sole therapy, or one of a limited set of available therapies, to treat serious human disease (World Health Organization, 2011) . The source of antibiotic-resistant bacteria may be vertical transmission of resistance gene determinants along the poultry chain. Zurfluh et al. (2014) provided evidence that gene determinants of ESBL-producing E. coli are transmitted vertically in the broiler production a,b means in the same row with no common superscripts are significantly different (P ≤ 0.05); ± standard error.
pyramid from the top (nucleus poultry flock level) to the bottom, with little evidence of any antibiotic selection pressure.
Because only one fecal samples was received on d 1 of the trial, findings from this day cannot be directly compared to the other days of the trial, where 24 cecal samples per sampling day were available. Additionally, on d 17 and 38 of the experiment, a high prevalence around 6 log 10 CFU/g of E. coli resistant to ampicillin, ciprofloxacin, streptomycin, sulfamethoxazole, and tetracycline was detected in all groups (Tables 3 and 4 ). According to the European summary report on antibiotic resistance, the average percent of resistance to ampicillin is 59%, for ciprofloxacin is 66%, for sulfamethoxazole is 53% and for tetracycline is 50% in E. coli from poultry in 28 countries in the EU (EFSA/ECDC et al., 2016) . Smith et al. (2007) found a high prevalence of resistance to tetracycline, sulfonamides, and streptomycin in commercial flocks, although these antibiotics were not used in most cases. The same study states that the ecology of bacterial communities present in animal environments plays an important role in the prevalence of antibiotic resistance. Supplementation of the diet with FA and treatment of broilers with AB did not have a significant influence on the total number of E. coli on d 17 and d 38 of the trial when enumerated without antibiotics present in the media. An influence of FA and AB on the microbial count of some AR E. coli in the cecum was shown in Tables 3 and 4 . There was no effect (P ≤ 0.05) of FA on resistant E. coli numbers on day 17, except for lower (P ≤ 0.05) numbers of streptomycin-resistant E. coli compared to the AB group. In the AB group, the level of cefotaxime-resistant E. coli and ESBL-producing E. coli was lower compared to the other 2 feeding groups on d 17 of the trial. Treatment with AB reduced the level of ESBL-producing E. coli in the cecum of broilers. Similar results were found in other studies. In fact, da Costa et al. (2011) report that E. coli strains displaying resistance to cephalothin were selected after the use of enrofloxacin. Additionally, ESBL-producing E. coli may also be resistant to fluoroquinolones, as reported by Su et al. (2016) .
The number of E. coli resistant to ciprofloxacin, sulfamethoxazole, and tetracycline was higher (P ≤ 0.05) in the AB group than in the control group on d 17 of the trial. Da Costa et al. (2011) also reports increased prevalence of resistance to unrelated antibiotics in medicated broilers upon exposure to enrofloxacin. The level of E. coli resistant to streptomycin was higher (P ≤ 0.05) in the enrofloxacin group compared to the FA group on d 17 of the trial. In general, 3 d of treatment with enrofloxacin resulted in increased (P ≤ 0.05) numbers of E. coli resistant to ciprofloxacin, sulfamethoxazole and tetracycline; the treatment decreased (P ≤ 0.05) the number of ESBL-producing E. coli in the AB group.
The microbiological analysis of control groups on d 17 and 38 of the trial show decreased numbers of E. coli resistant to ciprofloxacin, streptomycin, and sulfamethoxazole (P ≤ 0.05) with time. The level of ampicillin-and tetracycline-resistant E. coli in the FA group was significantly lower (P ≤ 0.05) than in the other 2 groups. Penicillins and tetracyclines are licensed for use in poultry in many countries, including large poultry producers such as the United States, Brazil, China, and the EU (Food and Drug Administration, 2016 (Pessanha and Filho, 2001; Lei et al., 2010; Ho et al., 2011; Jiang et al., 2011; Stella et al., 2013; Korb et al., 2015; Bezerra et al., 2016; EFSA/ECDC et al., 2016; Food and Drug Administration, 2016) . In the USA, rates of E. coli resistant to ampicillin are lower (20%) compared to other large poultry producers (Food and Drug Administration (2016) . The prevalence of ampicillin-resistant E. coli from broilers is 80% in China, 70% in Brazil and 60% in European Union (Pessanha and Filho, 2001; Yang et al., 2004; Dai et al., 2008; Lei et al., 2010; Lu et al., 2010; Ho et al., 2011; Jiang et al., 2011; Yu et al., 2012; Stella et al., 2013; Chen et al., 2014; Gai et al., 2015; Korb et al., 2015; Bezerra et al., 2016; EFSA/ECDC et al., 2016; Zhang et al., 2016) . Therefore, reducing the numbers of ampicillin-and tetracycline-resistant E. coli is of special importance. Confirmation of the literaturereported ability of organic acids and cinnamaldehyde to decrease the prevalence of ampicillin resistant E. coli in poultry was not obtained. However, the ability of organic acids and cinnamaldehyde to reduce E. coli counts in poultry is known (Raftari et al., 2009; Adil et al., 2010; Yossa et al., 2014) , and therefore, reduction of AR E. coli is possible. A significant reduction in total E. coli count was not observed in the present study. Therefore, a possible selective effect of FA on resistant E. coli should be investigated further. Additionally, the level of E. coli resistant to ciprofloxacin and sulfamethoxazole was lower (P ≤0.05) in the FA group compared to the AB group, but there was no significant difference (P > 0.05) compared to the control group. Microbiological analysis at the end of the trial showed that the level of cefotaxime-resistant E. coli and ESBL-producing E. coli was lower in the AB group compared to other groups, similar to the results for d 17. As expected, the level of E. coli resistant to ciprofloxacin was higher (P ≤ 0.05) in the group treated with enrofloxacin than in the 2 other groups. Thus, the use of enrofloxacin in broilers selects for ciprofloxacin resistant E. coli populations. This selection could also be detected in the present trial after 11 d of enrofloxacin use. Smith et al. (2007) reported that antibiotic use also creates resistant E. coli that can still compete with susceptible strains in the absence of antibiotic selective pressure. However, after increasing the prevalence of ciprofloxacin-resistant E. coli during enrofloxacin treatment for 3 d, as reported by da Costa et al. (2011) , the ciprofloxacin resistance level progressively approached that of the control group within the subsequent 11 d.
The present trial shows that FA can improve growth performance. Furthermore, the number of E. coli resistant to ampicillin, ciprofloxacin, sulfamethoxazole, and tetracycline was higher in the AB group compared to the FA group. Whether AB can be replaced for disease prevention and reduction of mortality with FA should be clarified with further trials.
CONCLUSION
A high prevalence of AR E. coli in all experimental groups was observed throughout the study. Dietary supplementation with FA and treatment of broilers with AB did not have a significant influence on the total number of E. coli on d 17 and d 38 of the trial. Supplementation with FA contributed to better growth performance and a decrease in ampicillin-and tetracyclineresistant E. coli in the cecum of broilers compared to control and AB group. The decrease (P ≤ 0.05) in sulfamethoxazole and ciprofloxacin-resistant E. coli compared to the AB group was observed in the FA group. Treatment of broilers with AB increased (P ≤ 0.05) the number of E. coli resistant to ciprofloxacin, streptomycin, sulfamethoxazole, and tetracycline in the cecum. However, fewer (P ≤ 0.05) E. coli were resistant to cefotaxime, and ESBL-producing E. coli was observed in the group treated with enrofloxacin.
